Login to Your Account

Big Biotechs On a Roll

Obesity, Cancer, Stem Cells Keep Investors Engaged in Q2

By Peter Winter

Monday, July 9, 2012

No prizes for guessing which company topped the list in recording the largest increase in its share price in the second quarter of 2012. Arena Pharmaceuticals Inc. won going away, thanks to the FDA's approval of Belviq (lorcaserin) the first new weight-loss drug for more than 13 years.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription